Researcher
Keio University School of Medicine, Tokyo, Japan
Makio Mukai is affliated to Department of Pathology, Keio University School of Medicine, Tokyo, Japan and has authored publications on "Bevacizumab Therapy". Makio Mukai is primarily interested in conducting research on Lung Cancer and Bevacizumab Therapy
Makio Mukai is primarily interested in conducting research on Lung Cancer and Bevacizumab Therapy
Pulmonary & Respiratory Medicine received 1690 citations as per Google Scholar report